Mkts

Myriad Genetics, Inc.

NASDAQ: MYGN
$5.53-0.01 (-0.18%)
As of Nov 18, 4:00 PM ET

Key statistics

Day range
5.495.70
52-week range
2.748.09
Today
Open5.55
Previous close5.53
Volume1.34M
Valuation
Market cap531.41M
P/E ratio—
EPS (TTM)-1.20
Income & risk
Dividend / yield—
Beta1.61
Avg volume2.27M
Discussion

MYGN News

Stories mentioning MYGN from around the web — every one is an open thread, so give it a like or add your take.

All news →

Loading news…

Financial statements

Financial statements

As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.

Line itemQ1 '26Mar 31Q4 '25Dec 31Q3 '25Sep 30Q2 '25Jun 30Q1 '25Mar 31Q4 '24Dec 31Q3 '24Sep 30Q2 '24Jun 30
Income Statement
Revenue200,400209,800205,700213,100195,900210,600213,300211,500
Cost of Goods Sold62,80063,00061,90061,30061,70059,70063,50064,400
Gross Profit137,600146,800143,800151,800134,200150,900149,800147,100
Operating Expenses
Research & Development27,10025,50028,20025,60027,50032,90028,50027,100
Sales General & Admin139,100144,900
Total Operating Expenses168,300152,500167,100481,000163,200190,000169,800183,600
Operating Income (Loss)(30,700)(5,700)(23,300)(329,200)(29,000)(39,100)(20,000)(36,500)
Interest Income700.00800.00500.00200.00300.00300.00400.00400.00
Interest Expense
Other Expense0.00400.00400.00(100.00)100.00300.00(800.00)(300.00)
Pretax Income(34,100)(8,900)(26,200)(330,600)(29,400)(39,200)(21,200)(37,200)
Tax Provision0.00(1,000)1,200(100.00)(29,300)3,300900.00(500.00)
Net Income (Loss)(34,100)(7,900)(27,400)(330,500)(100.00)(42,500)(22,100)(36,700)
Earnings Per Share (Basic)(0.36)(0.09)(0.29)(3.57)0.00(0.47)(0.24)(0.41)
Earnings Per Share (Diluted)(0.36)(0.09)(0.29)(3.57)0.00(0.47)(0.24)(0.41)
Weighted Average Shares Outstanding (Basic)93,70092,60093,10092,50091,40090,60090,90090,600
Weighted Average Shares Outstanding (Diluted)93,70092,60093,10092,50091,40090,60090,90090,600

Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.

Key facts

About MYGN

Myriad Genetics, Inc. (NASDAQ: MYGN) is a stock listed on the Nasdaq Stock Market under the ticker symbol MYGN. It last traded at $5.53 (Nov 18, 2026, 4:00 PM ET), down 0.2% on the day. That gives Myriad Genetics a market capitalisation of $531.4M.

Over the past 52 weeks MYGN has traded between $2.74 and $8.09.

Revenue for the quarter ended Mar 31, 2026 was $200.4M; a net loss of $34.1M. Revenue was up 2.3% from $195.9M in the quarter ended Mar 31, 2025.

Last 4 quarters
Quarter endedRevenueNet incomeMargin
Mar 31, 2026$200.4M-$34.1M-17.0%
Dec 31, 2025$209.8M-$7.9M-3.8%
Sep 30, 2025$205.7M-$27.4M-13.3%
Jun 30, 2025$213.1M-$330.5M-155.1%

From Myriad Genetics’s quarterly (10-Q) filings, in US dollars.

Latest News

Market news from around the web — every story is an open thread, so give it a like or add your take.

All news →

Loading news…